<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">MD-Onco</journal-id><journal-title-group><journal-title xml:lang="en">MD-Onco</journal-title><trans-title-group xml:lang="ru"><trans-title>MD-Onco</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2782-3202</issn><issn publication-format="electronic">2782-6171</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">118</article-id><article-id pub-id-type="doi">10.17650/2782-3202-2024-4-2-78-86</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSTIC CAPABILITIES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ВОЗМОЖНОСТИ ДИАГНОСТИКИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Sentinel lymph node mapping in patients with uterine cancer: current state of the problem. Literature review</article-title><trans-title-group xml:lang="ru"><trans-title>Картирование сигнальных лимфатических узлов у больных раком тела матки: современное состояние проблемы. Обзор литературы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-8863-6229</contrib-id><name-alternatives><name xml:lang="en"><surname>Polovodova</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Половодова</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Veronika V. Polovodova </bold></p><p><italic>63 14<sup>th</sup> Line St., Rostov-on-Don 344037</italic></p></bio><bio xml:lang="ru"><p><bold>Вероника Васильевна Половодова </bold></p><p><italic>344037 Ростов-на-Дону, ул. 14-я линия, 63</italic></p></bio><email>polovodovanika@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1084-5176</contrib-id><name-alternatives><name xml:lang="en"><surname>Verenikina</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Вереникина</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>63 14<sup>th</sup> Line St., Rostov-on-Don 344037</italic></p></bio><bio xml:lang="ru"><p><italic>344037 Ростов-на-Дону, ул. 14-я линия, 63</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7968-5078</contrib-id><name-alternatives><name xml:lang="en"><surname>Menshenina</surname><given-names>A. P.</given-names></name><name xml:lang="ru"><surname>Меньшенина</surname><given-names>А. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>63 14<sup>th</sup> Line St., Rostov-on-Don 344037</italic></p></bio><bio xml:lang="ru"><p><italic>344037 Ростов-на-Дону, ул. 14-я линия, 63</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9833-8530</contrib-id><name-alternatives><name xml:lang="en"><surname>Zhenilo</surname><given-names>O. E.</given-names></name><name xml:lang="ru"><surname>Женило</surname><given-names>О. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>63 14<sup>th</sup> Line St., Rostov-on-Don 344037</italic></p></bio><bio xml:lang="ru"><p><italic>344037 Ростов-на-Дону, ул. 14-я линия, 63</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6787-3007</contrib-id><name-alternatives><name xml:lang="en"><surname>Ardzha</surname><given-names>A. Yu.</given-names></name><name xml:lang="ru"><surname>Арджа</surname><given-names>А. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>63 14<sup>th</sup> Line St., Rostov-on-Don 344037</italic></p></bio><bio xml:lang="ru"><p><italic>344037 Ростов-на-Дону, ул. 14-я линия, 63</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-7909-2883</contrib-id><name-alternatives><name xml:lang="en"><surname>Rogozin</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Рогозин</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>63 14<sup>th</sup> Line St., Rostov-on-Don 344037</italic></p></bio><bio xml:lang="ru"><p><italic>344037 Ростов-на-Дону, ул. 14-я линия, 63</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7364-1963</contrib-id><name-alternatives><name xml:lang="en"><surname>Abdullayeva</surname><given-names>N. M.</given-names></name><name xml:lang="ru"><surname>Абдуллаева</surname><given-names>Н. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>63 14<sup>th</sup> Line St., Rostov-on-Don 344037</italic></p></bio><bio xml:lang="ru"><p><italic>344037 Ростов-на-Дону, ул. 14-я линия, 63</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9468-134X</contrib-id><name-alternatives><name xml:lang="en"><surname>Shevchenko</surname><given-names>A. N.</given-names></name><name xml:lang="ru"><surname>Шевченко</surname><given-names>А. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>63 14<sup>th</sup> Line St., Rostov-on-Don 344037</italic></p></bio><bio xml:lang="ru"><p><italic>344037 Ростов-на-Дону, ул. 14-я линия, 63</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2565-1518</contrib-id><name-alternatives><name xml:lang="en"><surname>Dimitriadi</surname><given-names>S. N.</given-names></name><name xml:lang="ru"><surname>Димитриади</surname><given-names>С. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>63 14<sup>th</sup> Line St., Rostov-on-Don 344037</italic></p></bio><bio xml:lang="ru"><p><italic>344037 Ростов-на-Дону, ул. 14-я линия, 63</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Medical Research Center for Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-06-14" publication-format="electronic"><day>14</day><month>06</month><year>2024</year></pub-date><volume>4</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>78</fpage><lpage>86</lpage><history><date date-type="received" iso-8601-date="2024-06-14"><day>14</day><month>06</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-06-14"><day>14</day><month>06</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, ABV-Press</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, АБВ-пресс</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">ABV-Press</copyright-holder><copyright-holder xml:lang="ru">АБВ-пресс</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://mdonco.abvpress.ru/jour/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://mdonco.abvpress.ru/jour/article/view/118">https://mdonco.abvpress.ru/jour/article/view/118</self-uri><abstract xml:lang="en"><p>Uterine cancer is one of the most common malignant diseases among female population. Surgical treatment is the main part of therapy but the question of lymph node dissection volume in patients with intermediate risk of uterine cancer metastasis remains open.</p><p>The article considers the concept of sentinel lymph node, anatomical characteristics of uterine lymphatic system. Description of various techniques for identification of sentinel lymph nodes, as well as clinical trial data evaluating their diagnostic effectiveness and sensitivity, are presented. Comparative analysis of the techniques and their combinations, drug administration routes is performed.</p></abstract><trans-abstract xml:lang="ru"><p>Рак тела матки – одно из самых распространенных онкологических заболеваний среди женского населения. Хирургическое лечение является основным этапом терапии, однако до сих пор остается открытым вопрос об объеме лимфодиссекции у больных с промежуточным риском метастазирования при раке тела матки.</p><p>В статье рассмотрены понятие сигнального лимфатического узла, анатомические особенности лимфатической системы тела матки. Приведены описания различных методик определения сигнальных лимфатических узлов, а также данные кли- нических исследований, оценивающих их диагностическую эффективность и чувствительность. Проведен сравнительный анализ методов оценки, а также их комбинаций, путей введения препаратов.</p><p> </p></trans-abstract><kwd-group xml:lang="en"><kwd>uterine body cancer</kwd><kwd>endometrial cancer</kwd><kwd>sentinel lymph node</kwd><kwd>ICG technique</kwd><kwd>radioisotope technique</kwd><kwd>methylene blue</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак тела матки</kwd><kwd>рак эндометрия</kwd><kwd>сигнальный лимфатический узел</kwd><kwd>ICG-метод</kwd><kwd>радиоизотопный метод</kwd><kwd>метиленовый синий</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Kit O.I., Kovalenko N.V., Maksimov A.Yu., Verenikina E.V. Bioinformational and clinical aspects of identification of differentially expressed genes by tumor cells in endometrial carcinoma and rare forms of uterine body cancer. Meditsinskiy vestnik Severnogo Kavkaza = Medical News of the North Caucasus 2023;18(1):37–41. (In Russ.). DOI: 10.14300/mnnc.2023.18009</mixed-citation><mixed-citation xml:lang="ru">Кит О.И., Коваленко Н.В., Максимов А.Ю., Вереникина Е.В. Биоинформационные и клинические аспекты идентификации дифференциально экспрессируемых генов опухолевыми клетками при эндометриальной карциноме и редких формах рака тела матки. Медицинский вестник Северного Кавказа 2023;18(1):37–41. DOI: 10.14300/mnnc.2023.18009</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Rykov M.Yu., Venediktova M.G. Clinical lectures on oncogynecology: a guide. Moscow: GEOTAR-Media, 2022. 320 p. (In Russ.). DOI: 10.33029/9704-6967-5-КTO-2022-1-320</mixed-citation><mixed-citation xml:lang="ru">Рыков М.Ю., Венедиктова М.Г. Клинические лекции по онкогинекологии: руководство. М.: ГЭОТАР-Медиа, 2022. 320 с. DOI: 10.33029/9704-6967-5-КTO-2022-1-320</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Oncogynecology: national guide. Ed. by A.D. Kaprin, L.A. Ashrafyan, I.S. Stylidi. Moscow: GEOTAR-Media, 2023. 384 p. (In Russ.). DOI: 10.33029/9704-5329-2-ONR-2019-1-384</mixed-citation><mixed-citation xml:lang="ru">Онкогинекология: национальное руководство. Под ред. А.Д. Каприна, Л.А. Ашрафяна, И.С. Стилиди. М.: ГЭОТАРМедиа, 2023. 384 с. DOI: 10.33029/9704-5329-2-ONR-2019-1-384</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><mixed-citation>Wagner M.M., van der Zee A.G.J., Oonk M.H.M. History and updates of the GROINSS-V studies. Cancers (Basel) 2022;14(8):1956. DOI: 10.3390/cancers14081956</mixed-citation></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Kagan I.I. Clinical anatomy of the female pelvis: illustrated author’s cycle of lectures. Ed. by G.T. Sukhikh. Moscow: GEOTAR-Media, 2021. 152 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Каган И.И. Клиническая анатомия женского таза: иллюстрированный авторский цикл лекций. Под ред. Г.Т. Сухих. М.: ГЭОТАР-Медиа, 2021. 152 с.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Nechushkina V.M., Kolomiets L.A., Kravets O.A. et al. Practical recommendations for the drug treatment of the uterine body cancer and uterine sarcomas. Practical recommendations of the Russian Society of Clinical Oncology. Part 1. Zlokachestvenniye opukholi = Malignant Tumors 2023;13(3S2):263–79. (In Russ.). DOI: 10.18027/2224-5057-2023-13-3s2-1-263-279</mixed-citation><mixed-citation xml:lang="ru">Нечушкина В.М., Коломиец Л.А., Кравец О.А. и др. Практические рекомендации по лекарственному лечению рака тела матки и сарком матки. Практические рекомендации RUSSCO, часть 1. Злокачественные опухоли 2023;13(3S2):263–79. DOI: 10.18027/2224-5057-2023-13-3s2-1-263-279</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><mixed-citation>Tanis P.J., Nieweg O.E., Vald’s Olmos R.A. et al. History of sentinel node and validation of the technique. Breast Cancer Res 2001;3(2):109–12. DOI: 10.1186/bcr281</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gould E.A., Winship T., Philbin P.H., Kerr H.H. Observations on a “sentinel node” in cancer of the parotid. Cancer 1960;13:77–8. DOI: 10.1002/1097-0142(196001/02)13:13.0.co;2-d</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 1977;39(2):456–66. DOI: 10.1002/1097-0142(197702)39:23.0.co;2-i</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Salman L., Cusimano M.C., Marchocki Z., Ferguson S.E. Sentinel lymph node mapping in high-grade endometrial cancer. Curr Oncol 2022;29(2):1123–35. DOI: 10.3390/curroncol29020096</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Krag D.N., Anderson S.J., Julian T.B. et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11(10):927–33. DOI: 10.1016/S1470-2045(10)70207-2</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Oonk M.H., van Hemel B.M., Hollema H. et al. Size of sentinelnode metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010;11(7):646–52. DOI: 10.1016/S1470-2045(10)70104-2</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Morton D.L., Wen D.R., Wong J.H. et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127(4):392–9. DOI: 10.1001/archsurg.1992.01420040034005</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220(3):391–8; discussion 398–401. DOI: 10.1097/00000658-199409000-00015</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Restaino S., Ronsini C., Finelli A. et al. Role of blue dye for sentinel lymph node detection in early endometrial cancer. Gynecol Surg 2017;14(1):23. DOI: 10.1186/s10397-017-1026-0</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Du J., Li Y., Wang Q. et al. Sentinel lymph node mapping in gynecological oncology. Oncol Lett 2017;14(6):7669–75. DOI: 10.3892/ol.2017.7219</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Bézu C., Coutant C., Salengro A. et al. Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol 2011;20(1):e55–9. DOI: 10.1016/j.suronc.2010.10.002</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Krag D.N., Weaver D.L., Alex J.C., Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2(6):335–9; discussion 340. DOI: 10.1016/0960-7404(93)90064-6</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Perissinotti A., Paredes P., Vidal-Sicart S. et al. Use of SPECT/CT for improved sentinel lymph node localization in endometrial cancer. Gynecol Oncol 2013;129(1):42–8. DOI: 10.1016/j.ygyno.2013.01.022</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Chernov V.I., Sinilkin I.G., Zelchan R.V. et al. Experimental study of 99mTc-aluminum oxide use for sentinel lymph nodes detection. Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications (PC’16). AIP Conf Proc 2016;1760:020012. DOI: 10.1063/1.4960231</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Chemyshova A.L., Kolomiets L.A., Sinilkin I.G. et al. Optimization of the extent of surgical treatment in patients with stage I in cervical cancer. Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications (PC’16). AIP Conf Proc 2016;1760:020013. DOI: 10.1063/1.4960232</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Eshima D., Fauconnier T., Eshima L., Thornback J.R. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med 2000;30(1):25–32. DOI: 10.1016/S0001-2998(00)80059-8</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Unkart J.T., Hosseini A., Wallace A.M. Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: results from a randomized, blinded clinical trial. J Surg Oncol 2017;116(7):819–23. DOI: 10.1002/jso.24735</mixed-citation></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Chernyshova L.A., Kolomiets L.A., Chernov V.I. Radical trachelectomy for cervical cancer. Novosibirsk: Siberian Branch of RAS, 2020. 147 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Чернышова Л.А., Коломиец Л.А., Чернов В.И. Радикальная трахелэктомия при раке шейки матки. Новосибирск: Издательство СО РАН, 2020. 147 с.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Chernyshova A.L., Kolomiec L.A., Chernov V.I., Sinilkin I.G. Detection of sentinel lymph nodes in organ-preserving treatment for invasive cervical cancer. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2018;17(1):82–91. (In Russ.). DOI: 10.21294/1814-48612018-17-1-82-91</mixed-citation><mixed-citation xml:lang="ru">Чернышова А.Л., Коломиец Л.А., Чернов В.И., Синилкин И.Г. Выявление сторожевых лимфатических узлов при органосохраняющем лечении инвазивного рака шейки матки. Сибирский онкологический журнал 2018;17(1):82–91. DOI: 10.21294/1814-48612018-17-1-82-91</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><mixed-citation>Pollard J.H., Raman C., Zakharia Y. et al. Quantitative test-retest measurement of 68Ga-PSMA-HBED-CC in tumor and normal tissue. J Nucl Med 2020;61(8):1145–52. DOI: 10.2967/jnumed.119.236083</mixed-citation></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Shevchuk A.S., Krylov A.S., Knyazev R.I., Afanasieva K.V. Determination of sentinel lymph nodes in gynecological cancer using the radiopharmaceutical sentiscan. A case series. Sovremennaya onkologiya = Journal of Modern Oncology 2023;25(1): 91–8. (In Russ.). DOI: 10.26442/18151434.2023.1.202140</mixed-citation><mixed-citation xml:lang="ru">Шевчук А.С., Крылов А.С., Князев Р.И., Афанасьева К.В. Определение сторожевых лимфатических узлов при гинекологическом раке с использованием радиофармпрепарата Сентискан, 99mTc. Современная онкология 2023;25(1):91–8. DOI: 10.26442/18151434.2023.1.202140</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><mixed-citation>Kraft O., Havel M. Detection of sentinel lymph nodes in gynecologic tumours by planar scintigraphy and SPECT/CT. Mol Imaging Radionucl Ther 2012;21(2):47–55. DOI: 10.4274/Mirt.236</mixed-citation></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Kanaev S.V., Bisyarin M.I., Krzhivitskiy P.I. et al. Preoperative SPECT-CT visualization of sentinel lymph nodes in patients with cervical cancer: preliminary analysis of the data. Voprosy onkologii = Problems in Oncology 2019;65(4):524–31. (In Russ.). DOI: 10.37469/0507-3758-2019-65-4-524-531</mixed-citation><mixed-citation xml:lang="ru">Канаев С.В., Бисярин М.И., Крживицкий П.И. и др. Предоперационная ОФЭКТ-КТ визуализация сигнальных лимфатических узлов у больных раком шейки матки: предварительный анализ полученных данных. Вопросы онкологии 2019;65(4):524–31. DOI: 10.37469/0507-3758-2019-65-4-524-531</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Bosenko E.S., Luganskaya R.G., Shatova Yu.S. et al. Experience of sentinel lymph node biopsy technique in patients with breast cancer at Rostov Research Institute of Oncology. Mezhdunarodniy zhurnal prikladnikh i fundamentalnikh issledovaniy = International Journal of Applied and Fundamental Research 2019;5:57–61. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Босенко Е.С., Луганская Р.Г., Шатова Ю.С. и др. Опыт применения методики биопсии сигнальных лимфатических узлов у больных раком молочной железы в ФГБУ «Ростовский научно-исследовательский онкологический институт» МЗ РФ. Международный журнал прикладных и фундаментальных исследований 2019;5:57–61.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><mixed-citation>Handgraaf H.J., Verbeek F.P., Tummers Q.R. et al. Real-time nearinfrared fluorescence guided surgery in gynecologic oncology: a review of the current state of the art. Gynecol Oncol 2014;135:606–13. DOI: 10.1016/j.ygyno.2014.08.005</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Bogani G., Raspagliesi F., Leone Roberti Maggiore U., Mariani A. Current landscape and future perspective of sentinel node mapping in endometrial cancer. J Gynecol Oncol 2018;29(6):e94. DOI: 10.3802/jgo.2018.29.e94</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Frumovitz M., Plante M., Lee P.S. et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol 2018;19(10):1394–403. DOI: 10.1016/S1470-2045(18)30448-0</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Sinno A.K., Fader A.N., Roche K.L. et al. A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer. Gynecol Oncol 2014;134(2):281–6. DOI: 10.1016/j.ygyno.2014.05.022</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Persson J., Salehi S., Bollino M. et al. Pelvic sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)- the final step towards a paradigm shift in surgical staging. Eur J Cancer 2019;116:77–85. DOI: 10.1016/j.ejca.2019.04.025</mixed-citation></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Alimov V.A., Skugarev S.A., Grekov D.N. et al. Diagnostic value of ICG for sentinel lymph node mapping in patients with stage I endometrial cancer. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2023;22(6):35–44. (In Russ.). DOI: 10.21294/1814-4861-2023-22-6-35-44</mixed-citation><mixed-citation xml:lang="ru">Алимов В.А., Скугарев С.А., Греков Д.Н. и др. Диагностическая значимость ICG-картирования сторожевых лимфоузлов у больных раком эндометрия I стадии. Сибирский онкологический журнал 2023;22(6):35–44. DOI: 10.21294/1814-4861-2023-22-6-35-44</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><mixed-citation>Van de Lande J., Torrenga B., Raijmakers P.G. et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol 2007;106(3):604–13. DOI: 10.1016/j.ygyno.2007.05.010</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Niikura H., Kaiho-Sakuma M., Tokunaga H. et al. Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 2013;131(2):299–303. DOI: 10.1016/j.ygyno.2013.08.018</mixed-citation></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">Berlev I.V., Ulrikh E.A., Ibragimov Z.N. et al. Possibilities of detection of sentinel lymph nodes in endometrial cancer by radioisotope and fluorescent (ICG) methods. Voprosy onkologii = Problems in Oncology 2017;63(2):304–8. (In Russ.). DOI: 10.37469/0507-3758-2017-63-2-304-308.</mixed-citation><mixed-citation xml:lang="ru">Берлев И.В., Ульрих Е.А., Ибрагимов З.Н. и др. Возможности детекции сигнальных лимфатических узлов при раке эндометрия радиоизотопным и флуоресцентным (ICG) методами. Вопросы онкологии 2017;63(2):304–8. DOI: 10.37469/0507-3758-2017-63-2-304-308</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><mixed-citation>Buda A., Crivellaro C., Elisei F. et al. Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: comparison with conventional radiotracer 99mTc and/or blue dye. Ann Surg Oncol 2016;23(7):2183–91. DOI: 10.1245/s10434-015-5022-1</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Verbeek F.P., Tummers Q.R., Rietbergen D.D. et al. Sentinel lymph node biopsy in vulvar cancer using combined radioactive and fluorescence guidance. Int J Gynecol Cancer 2015;25(6):1086–93. DOI: 10.1097/IGC.0000000000000419</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Eriksson A.G., Montovano M., Beavis A. et al. Impact of obesity on sentinel lymph node mapping in patients with newly diagnosed uterine cancer undergoing robotic surgery. Ann Surg Oncol 2016;23(8):2522–8. DOI: 10.1245/s10434-016-5134-2</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Abu-Rustum N.R. Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. J Natl Compr Cancer Network 2014;12(2):288–97. DOI: 10.6004/jnccn.2014.0026</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Reneé Franklin C., Tanner E.J. 3rd. Where are we going with sentinel lymph node mapping in gynecologic cancers? Curr Oncol Rep 2018;20(12):96. DOI: 10.1007/s11912-018-0744-4</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Abu-Rustum N.R., Khoury-Collado F., Gemignani M.L. Techniques of sentinel lymph node identification for early-stage cervical and uterine cancer. Gynecol Oncol 2008;111(2 Suppl): S44–50. DOI: 10.1016/j.ygyno.2008.07.027</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Khoury-Collado F., Abu-Rustum N.R. Lymphatic mapping in endometrial cancer: a literature review of current techniques and results. Int J Gynecol Cancer 2008;18(6):1163–8. DOI: 10.1111/j.1525-1438.2007.01188.x</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Cousins A., Thompson S.K., Wedding A.B., Thierry B. Clinical relevance of novel imaging technologies for sentinel lymph node identification and staging. Biotechnol Adv 2014;32(2):269–79. DOI: 10.1016/j.biotechadv.2013.10.011</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Ditto A., Casarin I., Pinelli C. et al. Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: a multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group. Eur J Cancer 2020;140:1–10. DOI: 10.1016/j.ejca.2020.08.030</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Cormier B., Rozenholc A.T., Gotlieb W. et al. Sentinel lymph node procedure in endometrial cancer: a systematic review and proposal for standardization of future research. Gynecol Oncol 2015;138(2):478–85. DOI: 10.1016/j.ygyno.2015.05.039</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Abu-Rustum N., Yashar C., Arend R. et al. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2023;21(2):181–209. DOI: 10.6004/jnccn.2023.0006</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Concin N., Matias-Guiu X., Vergote I. et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 2021;31(1):12–39. DOI: 10.1136/ijgc-2020-002230</mixed-citation></ref></ref-list></back></article>
